You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Peru Patent: 20191655


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Peru Patent: 20191655

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 5, 2033 Array Biopharma Inc BRAFTOVI encorafenib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Peru Patent PE20191655

Last updated: August 12, 2025


Introduction

Patent PE20191655, granted in Peru, pertains to a novel drug composition or therapeutic method, reflecting recent innovations in pharmaceutical science. This analysis dissects the patent’s scope and claims, examines its technological landscape, and assesses its IP strategic positioning within Peru and globally.


Patent Identification and Background

Patent Number: PE20191655
Grant Year: 2019 (assumed based on patent number)
Jurisdiction: Peru
Application Filing Date: Information specific to the applicant, likely in 2018 or 2019
Assignee: (Pending or presumed) – unspecified; likely pharmaceutical entity or research entity based on the innovation

Note: The specific technology focus of PE20191655 requires detailed review of the patent document (not provided). The analysis proceeds assuming a typical pharmaceutical patent with claims covering a novel active pharmaceutical ingredient (API), formulation, or use.


Scope of the Patent

Technological Domain

Peruvian patents in the pharmaceutical domain generally include composition claims, process claims, or use claims. PE20191655 likely covers:

  • A novel chemical entity or formulation
  • Method of preparation or synthesis
  • Therapeutic use for specific medical conditions

Given the context, the patent's scope probably encompasses at least one of these categories, with a focus on protecting the innovative aspects against competitors.

Territorial Scope

As a Peruvian patent, PE20191655 confers exclusive rights within Peru's jurisdiction. Its scope is limited geographically but can serve as a strategic patent in Latin America, especially if extended via regional treaties like the Andean Community or PCT applications.

Duration

Peru grants patents for 20 years from the filing date, subject to annual maintenance fees. The scope remains enforceable throughout this term, provided renewal fees are paid punctually.


Claims Analysis

Claim Structure

Peruvian patents typically include:

  • Independent claims: Broadly define the core invention
  • Dependent claims: Add specific limitations or embodiments

Scope of Claims

While the actual claims are unavailable, standard claims in such patents often cover:

  • A pharmaceutical composition comprising a novel active compound or combination, possibly with excipients or delivery agents.
  • A process for synthesizing the active compound involving specific reaction steps or catalysts.
  • Use claims indicating therapeutic applications, such as treatment of particular diseases (e.g., cancer, infectious diseases).

Claim Merit and Breadth

Peru’s patent system allows for relatively broad claims if adequately supported by the patent disclosure. A well-constructed patent would seek to maximize claim breadth without sacrificing novelty or inventive step.


Patent Landscape Analysis

Global Context

Peru's pharmaceutical patent landscape is evolving, influenced by international agreements like TRIPS and the Patent Cooperation Treaty (PCT). Latin American countries often focus on securing broad, enforceable patents, with a rising number of filings for innovative biologics and small-molecule drugs.

Regional and Local Innovation

  • Local R&D: Peru has a growing biosciences sector but faces challenges due to limited local patenting activity compared to global pharma giants.
  • Regional Filings: Many innovators pursue regional patents (e.g., in neighboring Colombia, Brazil) for broader rights.

Competitor Analysis

Existing patents in Latin America primarily cover formulations of established drugs, with fewer recent filings for novel APIs. PE20191655’s innovation might target a niche or underserved medical area, potentially providing competitive advantage.

Patent Family and Related Rights

Since patent PE20191655 is likely part of a broader patent family, it may have counterparts filed in other jurisdictions. This global strategy enhances market protection and licensing opportunities.


Legal and Strategic Considerations

  • Patent Validity and Enforceability: The patent’s validity depends on compliance with local patentability standards—novelty, inventive step, and industrial applicability.
  • Patent Life Cycle: Maximizing patent term and managing patent expirations is vital for commercialization strategies.
  • Freedom-to-Operate Analysis: Investigating existing patents in Peru and neighboring markets is essential before commercial deployment.

Implication for Stakeholders

  • Pharmaceutical Innovators: PE20191655 potentially secures exclusivity for a novel therapeutic, enabling market entry and licensing revenues.
  • Legal/IP Professionals: Ensuring robust claim language enhances enforceability; monitoring for patent infringement is crucial.
  • Regulatory Bodies: Patent landscape insights inform licensing, pricing, and access decisions.

Conclusion

Patent PE20191655 exemplifies a strategic effort to protect innovation within the Peruvian pharmaceutical space. Its scope, likely comprising a combination of composition, process, and use claims, with a focus on specific medical indications, aligns with regional patenting norms. The patent landscape indicates a competitive environment where patent strength can be decisive for commercial success, especially amid evolving legislation and international treaties.


Key Takeaways

  • Strategic Claim Drafting Is Crucial: Broad yet defensible claims maximize commercial protection and deter infringement.
  • Patent Landscape Awareness: Understanding regional and global patent activities enhances strategic positioning.
  • Regional Expansion Opportunities: Extending patent rights beyond Peru amplifies market reach.
  • Alignment with Regulatory Pathways: Patent strength supports regulatory approvals and market exclusivity.
  • Ongoing Monitoring: Vigilance over competitors’ filings sustains competitive advantage.

FAQs

1. What is the scope of patent PE20191655?
It likely covers a novel pharmaceutical composition, its synthesis process, or therapeutic use, aiming to protect the core innovation within Peru.

2. How does Peru’s patent system impact pharmaceutical patenting?
Peru allows patents up to 20 years, emphasizing novelty, inventive step, and industrial applicability. However, patent breadth depends on claim drafting quality and compliance with local standards.

3. Can PE20191655 be extended to other countries?
Yes. Filing through regional systems like the PCT can facilitate international patent protection. However, national phase entries are needed in each jurisdiction.

4. What challenges could affect the patent’s enforceability?
Prior art citations, claim clarity, and compliance with formal requirements influence enforceability. Additionally, local patent laws may evolve, impacting the patent’s strength.

5. How does the patent landscape influence drug commercialization in Peru?
A strong patent provides exclusivity, encouraging investment and R&D. Conversely, dense patent landscapes may pose freedom-to-operate challenges requiring careful legal analysis.


References

[1] Peru Patent Office (INDECOPI). "Patent Regulations and Guidelines."
[2] World Intellectual Property Organization (WIPO). "Patent Landscape Reports for Latin America."
[3] TRIPS Agreement, World Trade Organization.
[4] Latin American Patent Databases.
[5] Pharmaceutical patent law in Peru, official legislative texts.


Note: The specifics of patent PE20191655, including its precise claims and technological scope, should be obtained directly from the patent document for an authoritative, detailed analysis.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.